Monpat Chamnanphon

1.2k total citations
36 papers, 522 citations indexed

About

Monpat Chamnanphon is a scholar working on Oncology, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Monpat Chamnanphon has authored 36 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pharmacology and 8 papers in Cognitive Neuroscience. Recurrent topics in Monpat Chamnanphon's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Autism Spectrum Disorder Research (8 papers). Monpat Chamnanphon is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Autism Spectrum Disorder Research (8 papers). Monpat Chamnanphon collaborates with scholars based in Thailand, United States and Netherlands. Monpat Chamnanphon's co-authors include Chonlaphat Sukasem, Natchaya Vanwong, Yaowaluck Hongkaew, Apichaya Puangpetch, Apichaya Puangpetch, Nattawat Ngamsamut, Penkhae Limsila, Wasun Chantratita, Ekawat Pasomsub and Phichai Chansriwong and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Pharmacology.

In The Last Decade

Monpat Chamnanphon

35 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monpat Chamnanphon Thailand 16 220 133 132 128 112 36 522
Apichaya Puangpetch Thailand 15 126 0.6× 41 0.3× 87 0.7× 148 1.2× 111 1.0× 29 412
Apichaya Puangpetch Thailand 16 107 0.5× 64 0.5× 37 0.3× 69 0.5× 89 0.8× 37 596
Dymphy Huntjens Belgium 13 90 0.4× 110 0.8× 22 0.2× 69 0.5× 58 0.5× 28 609
Lucy Goodman New Zealand 9 106 0.5× 172 1.3× 18 0.1× 53 0.4× 357 3.2× 19 758
Jennifer A. Graf United States 10 159 0.7× 110 0.8× 10 0.1× 75 0.6× 85 0.8× 15 607
Evan T. Ogburn United States 11 197 0.9× 116 0.9× 65 0.5× 23 0.2× 86 0.8× 11 567
Gershwin T. Blyden United States 12 148 0.7× 98 0.7× 27 0.2× 44 0.3× 103 0.9× 30 691
Takayuki Seo Japan 10 98 0.4× 246 1.8× 34 0.3× 314 2.5× 357 3.2× 15 532
Fernanda Rodrigues‐Soares Brazil 12 307 1.4× 113 0.8× 111 0.8× 35 0.3× 97 0.9× 32 527
Humberto Fariñas Spain 10 217 1.0× 81 0.6× 54 0.4× 46 0.4× 67 0.6× 17 345

Countries citing papers authored by Monpat Chamnanphon

Since Specialization
Citations

This map shows the geographic impact of Monpat Chamnanphon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monpat Chamnanphon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monpat Chamnanphon more than expected).

Fields of papers citing papers by Monpat Chamnanphon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monpat Chamnanphon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monpat Chamnanphon. The network helps show where Monpat Chamnanphon may publish in the future.

Co-authorship network of co-authors of Monpat Chamnanphon

This figure shows the co-authorship network connecting the top 25 collaborators of Monpat Chamnanphon. A scholar is included among the top collaborators of Monpat Chamnanphon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monpat Chamnanphon. Monpat Chamnanphon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanwong, Natchaya, Phichai Chansriwong, Thanyanan Reungwetwattana, et al.. (2024). Influence of DPYD gene polymorphisms on 5-Fluorouracil toxicities in Thai colorectal cancer patients. Cancer Chemotherapy and Pharmacology. 95(1). 2–2. 1 indexed citations
2.
Sukasem, Chonlaphat, et al.. (2024). The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine. The Application of Clinical Genetics. Volume 17. 95–105. 3 indexed citations
3.
Vanwong, Natchaya, Phichai Chansriwong, Thanyanan Reungwetwattana, et al.. (2022). Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients. Frontiers in Oncology. 12. 916650–916650. 6 indexed citations
4.
Chariyavilaskul, Pajaree, et al.. (2022). Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population. PLoS ONE. 17(2). e0263621–e0263621. 7 indexed citations
5.
Chamnanphon, Monpat, Andrea Gaedigk, Weerawat Manosuthi, et al.. (2021). Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients. Pharmacogenomics and Personalized Medicine. Volume 14. 915–926. 3 indexed citations
6.
Chamnanphon, Monpat, Wonngarm Kittanamongkolchai, Natavudh Townamchai, et al.. (2020). <p><em>SLCO1B1</em> and <em>ABCG2</em> Gene Polymorphisms in a Thai Population</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 521–530. 7 indexed citations
7.
Chansriwong, Phichai, Ekaphop Sirachainan, Thanyanan Reungwetwattana, et al.. (2020). Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific Reports. 10(1). 13486–13486. 28 indexed citations
8.
Chamnanphon, Monpat, Sookjaroen Tangwongchai, Chonlaphat Sukasem, et al.. (2020). <p>CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 543–551. 3 indexed citations
9.
Chamnanphon, Monpat, Apichai Khongphatthanayothin, Yong Poovorawan, et al.. (2020). Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation. Scientific Reports. 10(1). 18969–18969. 14 indexed citations
10.
Hongkaew, Yaowaluck, Sadeep Medhasi, Ekawat Pasomsub, et al.. (2018). UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder. The Pharmacogenomics Journal. 18(6). 740–748. 14 indexed citations
11.
Vanwong, Natchaya, Nattawat Ngamsamut, Yaowaluck Hongkaew, et al.. (2016). Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels. Drug Metabolism and Pharmacokinetics. 31(2). 156–162. 31 indexed citations
12.
Vanwong, Natchaya, Nattawat Ngamsamut, Sadeep Medhasi, et al.. (2016). Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 27(2). 185–191. 29 indexed citations
14.
Sukasem, Chonlaphat, Sadeep Medhasi, Ekawat Pasomsub, et al.. (2016). Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder. Neuropsychiatric Disease and Treatment. 12. 843–843. 14 indexed citations
15.
Puangpetch, Apichaya, et al.. (2016). CYP2D6 polymorphisms and their influence on risperidone treatment. Pharmacogenomics and Personalized Medicine. Volume 9. 131–147. 44 indexed citations
16.
Vanwong, Natchaya, Sadeep Medhasi, Nattawat Ngamsamut, et al.. (2014). Pharmacogenetics and Clinical Risk Factors for Risperidone- Related Weight Gain in Thai Autistic Spectrum Disorder Patients. 36(1). 13–25. 2 indexed citations
17.
Sukasem, Chonlaphat, Monpat Chamnanphon, Napatrupron Koomdee, et al.. (2014). Pharmacogenetics and Clinical Biomarkers for Subtherapeutic Plasma Efavirenz Concentration in HIV-1 Infected Thai Adults. Drug Metabolism and Pharmacokinetics. 29(4). 289–295. 16 indexed citations
18.
Sukasem, Chonlaphat, et al.. (2013). Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen. Pharmacogenomics and Personalized Medicine. 6. 37–37. 32 indexed citations
19.
Sukasem, Chonlaphat, Monpat Chamnanphon, Napatrupron Koomdee, et al.. (2013). High Plasma Efavirenz Concentration and CYP2B6 Polymorphisms in Thai HIV-1 Infections. Drug Metabolism and Pharmacokinetics. 28(5). 391–397. 19 indexed citations
20.
Sirachainan, Ekaphop, Monpat Chamnanphon, T. Sirisinha, et al.. (2012). Impact of CYP2D6 Polymorphisms on Tamoxifen Responses of Women with Breast Cancer: A Microarray-based Study in Thailand. Asian Pacific Journal of Cancer Prevention. 13(9). 4549–4553. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026